Sunday, June 15, 2025
26.8 C
Bengaluru

Pharma CEO Roundtable on 27th October 2021

Engaging Doctors – Physical, Digital & Hybrid: Translating Strategy Into Action

Keynote Address: Rajaram Narayanan, Managing Director, Sanofi India

Pharma professionals can sign up here to receive the link to view the Pharma CEO Roundtable 2021.

Panel Members:

Digital will NOT make the pharma sales job redundant. Anything else you’ve heard to the contrary – is a MYTH. In fact, digital technology, digital platforms, and digital tools are an enabler for any Pharma salesperson to execute with sharper impact and reduce wastage.

How will this happen? Join us on the 27th of October as we bring together veterans of the industry and discuss what it truly means to go digital, understand the customer journey, identify the gaps, and leverage content via the right channels.

Highlights of the Pharma CEO Roundtable 2021

  • Mapping the customer journey
  • Identifying and filling the need-gaps of doctors
  • Content curation: What is engaging and why does it matter?
  • The omnichannel approach
  • The Sanofi experience

So, cast your inhibitions and fears away – and jump on the digital bandwagon. Pharma professionals can sign up here to receive the link to view the Pharma CEO Roundtable 2021.

Hot this week

Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma

https://www.pharmamanufacturing.com/articles/2011/095 A quiet but seismic shift is underway in global...

Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?

A quiet but revolutionary milestone may be unfolding in...

AI and the Future of Pharma Field Sales: Boon or Bane?

India’s pharmaceutical industry runs on the strength of its...

Semaglutide – More Than Just a Patent Battle

The Delhi High Court has restrained Dr. Reddy’s and...

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

Topics

Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma

https://www.pharmamanufacturing.com/articles/2011/095 A quiet but seismic shift is underway in global...

Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?

A quiet but revolutionary milestone may be unfolding in...

AI and the Future of Pharma Field Sales: Boon or Bane?

India’s pharmaceutical industry runs on the strength of its...

Semaglutide – More Than Just a Patent Battle

The Delhi High Court has restrained Dr. Reddy’s and...

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...
spot_img

Related Articles

spot_imgspot_img